Green Day-Biotechs Are Running Again: ALKS, BIIB, GILD, VRTX

Jan. 21, 2014 3:03 PM ETXBI

324 Followers

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

http://www.raygent.com

ETF investing, Portfolio Strategy, Long/Short Equity

Seeking Alpha Analyst Since 2007

Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 35 years executive experience including Abbott and JNJ and has been involved three successful start-ups. Before starting Raygent and other companies he was also a Technology Transfer Officer at UCLA. He has a B.S. from Penn State University and an MBA from Rutgers University. His WEB site at www.raygent.com is currently focused in biopharmaceuticals, genomics and clinical diagnostics . Mr. Raynovich has extensive expertise in marketing and product development and provides business development consulting to early stage companies in biotechnology, diagnostics and imaging. The Rayno Life Science Portfolio was published on www.raygent.com and other trade media. Articles have been published on the following topics: Alzheimer Disease,Biomarkers, Genomics,Molecular Diagnostics, Oncology Drugs, Personalized Medicine, Targeted Therapy, Technology Trends, H1N1 and Government Policy on biotechnology. The Life Science Portfolio is up over 80% over a 24 mo. period as of 5/30/14and among the life science portfolio winners are ABAX, ALXN, AMRI, BIIB, CBST, GPRO, ILMN, QDEL,REGN, SGEN, and VPHM.

Life Science Stocks Moving Again-XBI up 1.54%

After a 15%+ move January YTD you would think it is time to step back and take some off. Today the rally was in a full bull MOde with biopharmaceutical stocks leading the way. Here are big upside movers among our focus stocks: ALKS up 2%, BIIB up 3.55%, GILD up 3.37%, IMGN up 5.3%, PCYC up 2.7% and VRTX up 3.8%. Vertex (VRTX) was added as a buy in November at $63. It was one of the few mid-cap laggards.

In the DX and Tools area we have Exact Sciences (EXAS) up 3.6% and Illumina (ILMN) up 2.67%.

Check out two movers not on our coverage list that are technically strong today: Foundation Medicine (FMI$31.42) and Pacific Biosciences (PACB$7.54). PacBio is a small cap genetic testing and sequencing play with a unique platform technology. Foundation Medicine provides analysis of cancer specimens for actionable molecular information about a patient's individual disease.

Disclosure: I am long PACB, .

Additional disclosure: I am long Fidelity Select Biotech FBIOX

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You